Changes of Tumor Infiltrating Lymphocytes after Core Needle Biopsy and the Prognostic Implications in Early Stage Breast Cancer : A Retrospective Study

被引:15
|
作者
Huang, Jiahui [1 ]
Chen, Xiaosong [1 ]
Fei, Xiaochun [2 ]
Huang, Ou [1 ]
Wu, Jiayi [1 ]
Zhu, Li [1 ]
He, Jianrong [1 ]
Chen, Weiguo [1 ]
Li, Yafen [1 ]
Shen, Kunwei [1 ]
机构
[1] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Comprehens Breast Hlth Ctr, 197 Ruijin Er Rd, Shanghai 200025, Peoples R China
[2] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Pathol, Shanghai, Peoples R China
来源
CANCER RESEARCH AND TREATMENT | 2019年 / 51卷 / 04期
基金
中国国家自然科学基金;
关键词
Breast neoplasms; Core needle biopsy; Surgery; Tumor infiltrating lymphocytes; Prognosis; NEOADJUVANT CHEMOTHERAPY; TRASTUZUMAB; BIOMARKER; THERAPY; HER2;
D O I
10.4143/crt.2018.504
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose The purpose of this study was to investigate the changes of tumor infiltrating lymphocytes (TILs) between core needle biopsy (CNB) and surgery removed sample (SRS) in early stage breast cancer patients and to identify the correlating factors and prognostic significance of TILs changes. Materials and Methods A retrospective study was carried out on 255 patients who received CNB and underwent surgical resection for invasive breast cancer. Stromal TILs levels of CNB and SRS were evaluated respectively. Tumors with >= 50% stromal TILs were defined as lymphocyte-predominant breast cancer (LPBC). Clinicopathological variables were analyzed to determine whether there were factors associated with TILs changes. Log-rank tests and Cox proportional hazards models were used to analyze the influences of TILs and TILs changes on survival. Results SRS-TILs (median, 10.0%) were significant higher than CNB-TILs (median, 5.0%; p < 0.001). Younger age (< 60 years, p=0.016) and long surgery time interval (STI, >= 4 days; p=0.003) were independent factors correlating with higher Ills changes. CNB-LPBC patients showed better breast cancer-free interval (BCFI, p=0.021) than CNB-non-LPBC (CNB-nLPBC) patients. Patients were categorized into four groups according to the LPBC change pattern from CNB to SRS: LPBC -> LPBC -> nLPBC -> nLPBC, nLPBC -> nPBC, and nLPBC -> nLPBC, with estimated 5-year BCFI 100%, 100%, 69.7%, and 86.0% (p=0.016). nLPBC -> nLPBC pattern was an independent prognostic factor of worse BCFI (hazard ratio, 2.19; 95% confidence interval, 1.06 to 4.53; p=0.035) compared with other patterns. Conclusion TILs were significantly higher in SRS than in CNB. Higher TILs changes were associated with younger age and long STI. Changing from nLPBC to LPBC after CNB indicated a worse BCFI, which needs further validation.
引用
收藏
页码:1336 / 1346
页数:11
相关论文
共 50 条
  • [1] Comparison of tumor-infiltrating lymphocytes of breast cancer in core needle biopsies and resected specimens: a retrospective analysis
    Cha, Yoon Jin
    Ahn, Sung Gwe
    Bae, Soong June
    Yoon, Chang Ik
    Seo, Jayeong
    Jung, Woo Hee
    Son, Eun Ju
    Jeong, Joon
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2018, 171 (02) : 295 - 302
  • [2] Comparison of tumor-infiltrating lymphocytes of breast cancer in core needle biopsies and resected specimens: a retrospective analysis
    Yoon Jin Cha
    Sung Gwe Ahn
    Soong June Bae
    Chang Ik Yoon
    Jayeong Seo
    Woo Hee Jung
    Eun Ju Son
    Joon Jeong
    [J]. Breast Cancer Research and Treatment, 2018, 171 : 295 - 302
  • [3] Tumor infiltrating lymphocytes in early breast cancer
    Pruneri, Giancarlo
    Vingiani, Andrea
    Denkert, Carsten
    [J]. BREAST, 2018, 37 : 207 - 214
  • [4] Prognostic Implications of Tumor-Infiltrating Lymphocytes in Association With Programmed Death Ligand 1 Expression in Early-Stage Breast Cancer
    Park, In Hae
    Kong, Sun-Young
    Ro, Jae Yoon
    Kwon, Youngmee
    Kang, Joo Hyun
    Mo, Hye Jin
    Jung, So-Youn
    Lee, Seeyoun
    Lee, Keun Seok
    Kang, Han-Sung
    Lee, Eunsook
    Joo, Jungnam
    Ro, Jungsil
    [J]. CLINICAL BREAST CANCER, 2016, 16 (01) : 51 - 58
  • [5] Prognostic significance of changes in tumor infiltrating lymphocytes and neutrophil-to-lymphocyte ratio after neoadjuvant chemotherapy in early breast cancer patients
    Garcia-Torralba, Esmeralda
    Alvarez-Abril, Beatriz
    Bravo-Perez, Carlos
    Manzano, Esther Navarro
    Barrio, Pilar de la Morena
    Rubio, Alejandra Ivars
    Garcia-Garre, Elisa
    Zafra, Gema Marin
    de la Pena, Francisco Ayala
    Garcia-Martinez, Elena
    [J]. CANCER RESEARCH, 2022, 82 (04)
  • [6] Association of tumor infiltrating lymphocytes with pathological response after neoadjuvant therapy in breast cancer: A retrospective study.
    Grover, Punita
    Phan, Kim
    Magge, Tara
    Chou, Andrew
    Naffouje, Rand
    Jandarov, Roman
    Grate, Lisa
    Hinrichs, Benjamin H.
    Charif, Mahmoud
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [7] Prognostic Factors and Tumor Infiltrating Lymphocytes in Triple Negative Breast Cancer
    Dulgar, Ozgecan
    Ilvan, Sennur
    Turna, Zeynep Hande
    [J]. EUROPEAN JOURNAL OF BREAST HEALTH, 2020, 16 (04) : 276 - 281
  • [8] Prognostic and Predictive Value of Tumor-Infiltrating Lymphocytes in Breast Cancer
    Kwa M.
    Adams S.
    [J]. Current Breast Cancer Reports, 2016, 8 (1) : 1 - 13
  • [9] Tumor-infiltrating lymphocytes as a prognostic factor in patients with stage I to III breast cancer.
    Richardet, Eduardo
    Acosta, Luciana Paola
    Paradelo, Martin
    Pairola, Martin
    Di Tada, Cecilia
    Molina, Matias
    Dicalbo, Luciano Salvador
    Villavicencio, Rocio Paola
    Richardet, Martin Eduardo
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [10] Tumor infiltrating lymphocytes (TILs) as prognostic biomarker in patients with breast cancer
    Denkert, C.
    [J]. BREAST, 2021, 56 : S5 - S5